|
Issue |
Title |
|
Vol 24, No 1 (2024) |
Requirements for the information on reference standards submitted in the dossier for biologicals |
Abstract
PDF (Rus)
|
R. A. Volkova, O. V. Fadeikina, O. B. Ustinnikova, K. A. Sarkisyan, A. A. Movsesyants, V. A. Merkulov, V. V. Kosenko |
|
Vol 24, No 1 (2024) |
Certification of a pharmacopoeial reference standard for potency testing of recombinant interferon α-2b |
Abstract
PDF (Rus)
|
L. A. Gaiderova, Yu. N. Lebedeva, T. N. Lobanova, E. K. Lipatova, R. A. Volkova, O. V. Fadeikina |
|
Vol 24, No 1 (2024) |
Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies |
Abstract
PDF (Rus)
|
E. V. Nozdrina, D. A. Mazalev, D. R. Rogozina, S. P. Zhivoderov, I. V. Lyagoskin, R. R. Shukurov |
|
Vol 24, No 1 (2024) |
Quantitative mass spectrometry with ¹⁸O labelling as an alternative approach for determining protease activity: an example of trypsin |
Abstract
PDF (Rus)
|
M. A. Konstantinov, D. D. Zhdanov, I. Yu. Toropygin |
|
Vol 24, No 1 (2024) |
Application of alternative identification methods for live tularaemia and brucellosis vaccines |
Abstract
PDF (Rus)
|
I. V. Kasina, S. A. Alekseeva, T. I. Nemirovskaya |
|
Vol 24, No 1 (2024) |
Quality analysis of BCG vaccine for bladder cancer immunotherapy using Shewhart control charts |
Abstract
PDF (Rus)
|
A. A. Savina, A. A. Voropaev, A. A. Alesina |
|
1 - 6 of 6 Items |
|